Brief: Vincerx Pharma Reposts $27.4 Mln In Cash, Cash Equivalents And Marketable Securities As Of June 30

Vincerx Pharma

07/08/2023 15:57

Aug 7 (Reuters) - Vincerx Pharma Inc  VINC.O :
    * VINCERX PHARMA INC - IND APPLICATION FILED FOR POTENTIAL
BEST-IN-CLASS ADC, VIP943; PHASE 1 TRIAL EXPECTED TO BEGIN Q4
2023
    * VINCERX PHARMA INC - CASH BALANCE EXPECTED TO SUPPORT
PLANNED
OPERATIONS INTO LATE 2024
    * VINCERX PHARMA INC - APPROXIMATELY $27.4 MILLION IN CASH,
CASH
EQUIVALENTS AND MARKETABLE SECURITIES AS OF JUNE 30, 2023

Source text for Eikon:  ID: 
Further company coverage:  VINC.O 

 ((Reuters.Briefs@thomsonreuters.com;))